Report an error

Spotted something inaccurate in “Sunvozertinib Shows 60% Response Rate Against Previously Untreatable Lung Cancer Mutations”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.